Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1464 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Pierre Fabre S.A.. (6/2/16). "Press Release: The »Toulouse Cancer Santé« Foundation and the Pierre Fabre Research Institute Launch an Immuno-Oncology Research Team at the Toulouse Oncopole Campus". Toulouse & Castres. 2016-06-02
Novacyt S.A.. (6/2/16). "Press Release: Novacyt Raises Additional €1.4m and Expands into new Primer Design Facilities". Paris & Cambridge. 2016-06-02
bioMérieux S.A.. (6/1/16). "Press Release: bioMérieux Acquires Hyglos and Expands Its Offering to the Detection of Endotoxins in Pharmaceutical Products". Marcy l’Étoile. 2016-06-01
Eurofins Scientific. (6/1/16). "Press Release: Eurofins Reinforces Its Leading Footprint in Food Testing in France with the Acquisition of Agro-Analyses". 2016-06-01
TxCell S.A.. (6/1/16). "Press Release: TxCell and the Lübeck Institute of Experimental Dermatology Launch Collaboration to Develop CAR-Tregs in Bullous Pemphigoid". Valbonne. 2016-06-01
Ipsen S.A.. (6/1/16). "Press Release: Eugenia Litz Is Appointed as Vice President Investor Relations of Ipsen". Paris. 2016-06-01
bioMérieux S.A.. (5/31/16). "Press Release: bioMérieux and the Lyon Civil Hospitals Strengthen Their Collaboration and Expand Their Partnership to Include Claude Bernard University Lyon 1". Marcy l’Étoile & Lyon. 2016-05-31
DBV Technologies S.A.. (5/31/16). "Press Release: DBV Technologies and Nestlé Health Science Form Collaboration to Develop and Commercialize a Novel Diagnostic Test for Pediatric Milk Allergy". Montrouge. 2016-05-31
TxCell S.A.. (5/25/16). "Press Release: TxCell Obtains Authorization from European Regulatory Authorities to Restart Ovasave Phase IIb Clinical Trial". Valbonne. 2016-05-25
Diaxonhit S.A.. (5/25/16). "Press Release: Diaxonhit and the University Hospitals of Strasbourg Launch the Central European Laboratory Dedicated to AlloMap Testing". Paris & Strasbourg. 2016-05-25
Sanofi S.A.. (5/23/16). "Press Release: Sanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020". Paris. 2016-05-23
Ipsen S.A.. (5/17/16). "Press Release: Ipsen Partners with IMCB to Advance Understanding and Research of Botulinum Neurotoxin Biology". Paris & Singapore. 2016-05-17
Neovacs S.A.. (5/17/16). "Press Release: Neovacs to Attend ChinaBio Event. May 18 & 19, 2016". Paris & Boston, MA. 2016-05-17
Neovacs S.A.. (5/12/16). "Press Release: Neovacs and Stellar Biotechnologies Sign Joint Venture Agreement to Create Neostell SAS". Paris & Boston, MA. 2016-05-12
Sanofi S.A.. (5/12/16). "Press Release: Sanofi Files for Hart-Scott-Rodino Notification Regarding Proposed Acquisition of Medivation. Reiterates Commitment to Consummating Transaction". Paris. 2016-05-12
Alizé Pharma S.A.S.. (5/11/16). "Press Release: Alizé Pharma II, a Company of the Alizé Pharma Group, Acquired by Jazz Pharmaceuticals". Lyon. 2016-05-11
Cellectis S.A.. (5/11/16). "Press Release: Cellectis Reports First Quarter 2016 Financial Results. Initiated UCART123 GMP Production Concept". New York, NY. 2016-05-11
Sanofi S.A.. (5/5/16). "Press Release: Sanofi Sends Letter to Medivation’s Board of Directors". Paris. 2016-05-05
Innate Pharma S.A.. (5/4/16). "Press Release: First Quarter 2016 Report. Cash, Cash Equivalents and Financial Instruments of the Company Amounted to €255.8 Million". Marseille. 2016-05-04
Ipsen S.A.. (5/3/16). "Press Release: Oncodesign and Ipsen Enter into a Strategic Partnership in Oncology and Oncodesign Joins Ipsen’s Paris-Saclay Campus". Paris & Dijon. 2016-05-03
Dassault Systèmes S.A.. (5/3/16). "Press Release: European Spallation Source Chose Dassault Systèmes’ 3DExperience Platform to Develop the World’s Leading Neutron Research Center". Vélizy-Villacoublay. 2016-05-03
Sanofi S.A.. (4/28/16). "Press Release: Sanofi Offers to Acquire Medivation for $52.50 per Share in Cash". Paris. 2016-04-28
Servier. (4/27/16). "Press Release: Patients with Advanced Metastatic Colorectal Cancer in Europe Now Have a New Treatment Option as Lonsurf (trifluridine/tipiracil) Receives EU Approval". Suresnes. 2016-04-27
Alizé Pharma S.A.S.. (4/26/16). "Press Release: Alizé Pharma Reports Positive Results from Its Phase II Clinical Trial of AZP-531 in Prader-Willi Syndrome". Lyon. 2016-04-26
TxCell S.A.. (4/25/16). "Press Release: TxCell and Ospedale San Raffaele Launch Collaboration for the Development of CAR-Tregs in Lupus Nephritis". Valbonne & Milan. 2016-04-25
TxCell S.A.. (4/25/16). "Press Release: Letter to Shareholders – from Stéphane Boissel, CEO of TxCell April 25, 2016". Valbonne & Milan. 2016-04-25
Dassault Systèmes S.A.. (4/21/16). "Press Release: Dassault Systèmes Reports Q1 Non-IFRS Total Revenues at High End of Guidance and Reaffirms 2016 Financial Objectives". Vélizy-Villacoublay. 2016-04-21
Enterome Bioscience S.A.. (4/20/16). "Press Release: Enterome Raises €14.5 Million in Series C Financing Round. Nestlé Health Science Invests alongside Existing Investors". Paris & Boston, MA. 2016-04-20
TxCell S.A.. (4/20/16). "Press Release: Financial Information for the 1st Quarter of 2016". Valbonne. 2016-04-20
PeptiMimesis. (4/20/16). "Press Release: PeptiMimesis Secures €1.2m ($1.4m) from Cap Innov’Est". Strasbourg. 2016-04-20
bioMérieux S.A.. (4/20/16). "Press Release: bioMérieux – First-quarter 2016 Business Review. Solid Growth in Sales, up 11.5% at Constant Exchange Rates and Scope of Consolidation". 2016-04-20
Evotec AG. (4/19/16). "Press Release: Evotec and Pierre Fabre Sign Multi-year Compound Management Agreement". Hamburg. 2016-04-19
Nicox S.A.. (4/19/16). "Press Release: Nicox Submits New Drug Application for AC-170 to U.S. FDA". Sophia Antipolis. 2016-04-19
AB Science S.A.. (4/18/16). "Press Release: AB Science Announces the Success of a Private Placement [Not for Distriubution, Publication, Release, Directly or Indirectly, in the United States, Canada, Australia or Japan]". Paris. 2016-04-18
Euronext N.V.. (4/15/16). "Press Release: Euronext Welcomes Swiss Biotechnology Pioneer GeNeuro to Paris Market. Raises €33 Million, Market Capitalisation Totals €190 Million". Paris. 2016-04-15
OSE Pharma S.A.. (4/15/16). "Press Release: OSE Pharma and Effimune Announce the Signing of the Merger Treaty to Create OSE Immunotherapeutics". Paris & Nantes. 2016-04-15
Nicox S.A.. (4/15/16). "Press Release: 2015 Financial Results and Business Update". Sophia Antipolis. 2016-04-15
ImaBiotech S.A.S.. (4/14/16). "Press Release: ImaBiotech Signs License Agreement with Lawrence Berkeley National Laboratory". Lille & Berkeley, CA. 2016-04-14
GeNeuro S.A.. (4/14/16). "Press Release: GeNeuro Sets Offer Price at €13 per Share [Not for Australia, Canada or Japan]". Geneva. 2016-04-14
Pierre Fabre S.A.. (4/14/16). "Press Release: Pierre Fabre Laboratories Sign a New Partnership with a Biotech Company from the Toulouse Region, VibioSphen, within the Framework of the Open Innovation Program »Nature Open Library«". Labège & Castres. 2016-04-14
Keranova. (4/11/16). "Press Release: Keranova Raises €4m ($4.55m) in Series A Funding. Investment Will Finance Development of Prototypes for New Ophthalmic Surgery Equipment". Saint-Etienne & Lyon. 2016-04-11
bioMérieux S.A.. (4/11/16). "Press Release: bioMérieux and Antwerp University Unveil the Final Results of the First Global Point Prevalence Survey of Antibiotic Use and Resistance Rates in Hospitals". Marcy l’Étoile & Antwerp. 2016-04-11
IntegraGen S.A.. (4/8/16). "Press Release: IntegraGen Reports 2015 Financial Results". Évry. 2016-04-08
MedDay Pharmaceuticals S.A.S.. (4/8/16). "Press Release: MedDay Secures €34 Million ($38.5M) New Funding". Paris. 2016-04-08
DBV Technologies S.A.. (4/7/16). "Press Release: DBV Technologies Reports Full Year 2015 Financial Results". 2016-04-07
Meiogenix S.A.S.. (4/6/16). "Press Release: Meiogenix Announces a Licensing Agreement with Bayer to Apply SpiX Technology in Crops". Paris. 2016-04-06
Ipsen S.A.. (4/5/16). "Press Release: Dassault Systèmes and Ipsen Sign Collaborative Agreement to Develop Innovative Programs to Support Ipsen’s Drug Discovery". Paris. 2016-04-05
Sanofi S.A.. (4/1/16). "Press Release: Sanofi and Regeneron Announce Positive Dupilumab Topline Results from Two Phase 3 Trials in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients". Paris & Tarrytown, NY. 2016-04-01
Servier. (4/1/16). "Press Release: Withdrawal of Fusafungine-containing Medicines from the Market". 2016-04-01
TxCell S.A.. (3/31/16). "Press Release: TxCell Appoints Its Global Scientific Advisory Board (“SAB”) Led by Professor Zelig Eshhar as Chairman". Valbonne. 2016-03-31
Keranova. (3/30/16). "Press Release: Keranova Opens Its Administrative Site at Vénissieux and Begins Construction on Its Headquarters in Saint Etienne". 2016-03-30
ImaBiotech S.A.S.. (3/29/16). "Press Release: ImaBiotech’s First Worldwide Patent Has Been Granted for Its Quantification Innovation in MSI". Lille. 2016-03-29
Sanofi S.A.. (3/29/16). "Press Release: Sanofi Appoints Dr. Yong-Jun Liu as Head of Research". Paris. 2016-03-29
Sanofi S.A.. (3/29/16). "Press Release: Sanofi Successfully Prices EUR 1.8 billion Bond Issue". Paris. 2016-03-29
Dassault Systèmes S.A.. (3/29/16). "Press Release: Dassault Systèmes and Inserm Announce Joint Agreement to Decipher Disease Complexity and Accelerate Clinical Research". Paris. 2016-03-29
Onxeo S.A.. (3/25/16). "Press Release: Onxeo Announces Closing of DNA Therapeutics Acquisition. Onxeo Gains Access to AsiDNA Compound, a First-in-class Signal Interfering DNA". Paris & Copenhagen. 2016-03-25
Genomic Vision S.A.. (3/22/16). "Press Release: 2015 Annual Results. All Planned 2015 Development Milestones Achieved". Bagneux. 2016-03-22
Bridgepoint. (3/22/16). "Press Release: Bridgepoint Development Capital Acquires French Dental Equipment Manufacturer Acteon". 2016-03-22
bioMérieux S.A.. (3/22/16). "Press Release: bioMérieux and Copan Announce the First Commercial Success of their Collaboration for the Automation and Efficiency of Microbiology laboratories". Marcy l’Étoile. 2016-03-22
MaaT Pharma. (3/22/16). "Press Release: MaaT Pharma Announces €10 million Fundraising and Pursues the Development of the First Worldwide Autologous Microbiotherapy Solution". Lyon. 2016-03-22
OSE Pharma S.A.. (3/21/16). "Press Release: 2015 Annual Results in Line with Forecasts, and Significant Clinical Advances. 2016 Outlook – Further Development and Merger Project with Effimune". Paris. 2016-03-21
Gecko Biomedical. (3/17/16). "Press Release: Gecko Biomedical Raises €22.5 Million Led by Sofinnova Partners". Paris. 2016-03-17
Deinove S.A.. (3/17/16). "Press Release: Deinove to Present at Upcoming U.S. Investors Conference". Montpellier. 2016-03-17
Sanofi S.A.. (3/16/16). "Press Release: Sanofi and DiCE Molecules Announce Research Collaboration to Discover Potential Therapeutics Based on Unique Small Molecule Discovery Platform". Paris & San Francisco, CA. 2016-03-16
TxCell S.A.. (3/15/16). "Press Release: TxCell Appoints PCT as Its US Manufacturing Partner". Valbonne. 2016-03-15
Abivax S.A.. (3/15/16). "Press Release: 2015 Full-Year Results and Progress Report. Significant Progress on Both Cornerstone Programs (HIV and HBV)". Paris. 2016-03-15
Deinove S.A.. (3/14/16). "Press Release: Deinove and Arbiom Joins Forces to Develop »Carbon-free« Chemical Industry". Montpellier. 2016-03-14
Cellectis S.A.. (3/14/16). "Press Release: Cellectis Reports Fourth Quarter and Full Year 2015 Financial Results". New York, NY. 2016-03-14
TxCell S.A.. (3/10/16). "Press Release: TxCell 2015 Results and Update on Strategy and Outlook". Valbonne. 2016-03-10
MorphoSys AG. (3/9/16). "Press Release: MorphoSys to Present at Upcoming Investor Conferences". 2016-03-09
Ipsen S.A.. (3/8/16). "Press Release: Ipsen and PeptiMimesis Announce a Research Partnership in Oncology". Paris & Strasbourg. 2016-03-08
Cerenis Therapeutics S.A.. (3/8/16). "Press Release: Cerenis Therapeutics Announces Its Participation to the 28th Roth Capital Partners Annual Conference". Toulouse & Ann Arbor, MI. 2016-03-08
Cellectis S.A.. (3/7/16). "Press Release: Cellectis Announces Presentation at the Cowen and Company 36th Annual Health Care Conference in Boston, March 7–9, 2016". New York, NY. 2016-03-07
Neovacs S.A.. (3/7/16). "Press Release: Neovacs Reports Full Year 2015 Finanical Results". Paris. 2016-03-07
Poxel S.A.. (3/4/16). "Press Release: Poxel to Present at 28th Annual Roth Conference". Lyon. 2016-03-04
bioMérieux S.A.. (3/2/16). "Press Release: 2015 Financial Results". 2016-03-02
Novasep S.A.. (3/2/16). "Press Release: Novasep Presents the Second Successful Year of Its »Back to Basics« Strategy and Preliminary 2015 Financial Results". Lyon Gerland. 2016-03-02
ImaBiotech S.A.S.. (3/16). "Press Release: Imabiotech Obtain 6M€ for a New European Project in Partnership with Lille I University and Cubic Pharmaceuticals". 2016-03-01
Ipsen S.A.. (3/1/16). "Press Release: Exelixis and Ipsen Enter into Exclusive Licensing Agreement to Commercialize and Develop Novel Cancer Therapy Cabozantinib in Regions Outside the United States, Canada and Japan". Paris & South San Francisco, CA. 2016-03-01
Ipsen S.A.. (3/1/16). "Press Release: Ipsen’s 2015 Results and 2016 Financial Objectives". Paris. 2016-03-01
PeptiMimesis. (2/29/16). "Press Release: PeptiMimesis – New Biotech Startup Developing Next Generation Therapeutic Peptides in Immuno-oncology, Oncology and Immune Diseases". Strasbourg. 2016-02-29
Genfit S.A.. (2/29/16). "Press Release: Genfit Raises EUR 49.6 Million in Private Placement [Not for publication or distribution in the United States, Canada, Australia or Japan]". Lille & Boston, MA. 2016-02-29
Onxeo S.A.. (2/29/16). "Press Release: Onxeo Announces Acquisition of DNA Therapeutics and Provides Update on Validive Development Plan". Paris & Copenhagen. 2016-02-29
Onxeo S.A.. (2/26/16). "Press Release: Onxeo Reports 2015 Full-Year Results and Provides Business Update". Paris & Copenhagen. 2016-02-26
Nanobiotix S.A.. (2/26/16). "Press Release: Nanobiotix 2015 Q4 and Annual Revenues". Paris. 2016-02-26
Servier. (2/26/16). "Press Release: Servier Receives Positive CHMP Opinion for LONSURF (trifluridine/tipiracil) for Refractory Metastatic Colorectal Cancer". Suresnes. 2016-02-26
OSE Pharma S.A.. (2/24/16). "Press Release: OSE Pharma and Effimune Announce Proposed Merger to Create Significant Immunotherapy Player". Paris & Nantes. 2016-02-24
Valneva S.E.. (2/24/16). "Press Release: Valneva Posts 96% Revenue Growth in 2015, Forecasts 2016 Revenues of €90 to €100 Million". Lyon. 2016-02-24
Pierre Fabre S.A.. (2/22/16). "Press Release: Plasticell and Pierre Fabre Laboratories Sign a Partnership to Identify Natural Stimulants of Brown Fat for Treatment and Prevention of Obesity and Diabetes". Stevenage & Castres. 2016-02-22
LFB S.A.. (2/22/16). "Press Release: Registration of FibCLOT, LFB’s Human Fibrinogen, in Europe". Les Ulis. 2016-02-22
Pharnext S.A.S.. (2/22/16). "Press Release: Pharnext Announces the Appointment of Niall Murphy as Chief Scientific Officer and Pierre Schwich as Chief Financial Officer". Paris. 2016-02-22
Onxeo S.A.. (2/22/16). "Press Release: Onxeo Expands Collaborations to Advance Development Program of Key Orphan Oncology Assets in Combination with Immuno-oncology Agents". Paris & Copenhagen. 2016-02-22
OSE Pharma S.A.. (2/22/16). "Press Release: First Patients Enrolled and Dosed in the Pivotal Trial of Phase 3 of the Immunotherapy Tedopi for Advanced Non-small Cell Lung Cancer". Paris. 2016-02-22
Cellnovo. (2/22/16). "Press Release: Cellnovo Appoints Thierry Moulin as Chief Financial Officer". Paris. 2016-02-22
Pherecydes Pharma S.A.. (2/22/16). "Press Release: Antibiotic resistance. Pherecydes Pharma Appoints Guy-Charles Fanneau de La Horie as Chief Executive Officer". Romainville. 2016-02-22
Onxeo S.A.. (2/17/16). "Press Release: Onxeo to Attend Upcoming Investor Conferences and Medical Meetings". Paris & Copenhagen. 2016-02-17
Ipsen S.A.. (2/17/16). "Press Release: Ipsen Enters into a Licensing Agreement with 3B Pharmaceuticals to Develop Novel Radiopharmaceuticals in Oncology". Paris. 2016-02-16
Servier. (2/12/16). "Press Release: EMA Benefit/Risk Revision of Fusafungine-containing Medicines". 2016-02-12
MilliDrop Instruments S.A.S.. (2/11/16). "Press Release: MilliDrop Raises €1 Million from Seventure Partners’ Quadrivium 1 Seed Fund". Paris. 2016-02-11
Abivax S.A.. (2/11/16). "Press Release: Abivax to Participate in the Upcoming RBC Capital Markets 2016 Healthcare Conference in New York, and in the Credit Suisse Healthcare Conference in London". Paris. 2016-02-11
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page



Advertisement

Picture [iito] – Putting Information into Context 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [iito] – Putting Information into Context 600x60px

» top